Inhibitor Therapeutics (INTI, $0.07) was a top weekly loser, falling to $0.07 per share. Of the 860 stocks analyzed in the Biotechnology Industry throughout the week of August 29 - September 5, of them (3) exhibited an Uptrend while of them (6) were in a Downtrend.